A Unified and Interpretable Benchmarking Framework for Brain Tumor Classification Using Classical and Deep Learning Models.
International Journal of Drug Delivery Technology · 13.03.2026 · 16 (8s)
DOI: 10.25258/ijddt.16.8s.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.03.2026. Verfasst von Preeti Jain und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Accurate detection of brain tumors from magnetic resonance imaging (MRI) remains a clinically critical yet computationally challenging task due to high-dimensional image complexity and sensitivity to diagnostic errors. This study presents a unified hybrid diagnostic framework that systematically integrates classical machine learning algorithms and deep neural architectures within a standardized and reproducible benchmarking environment. Unlike model-centric investigations that evaluate isolated classifiers, the proposed framework establishes a controlled cross-paradigm experimental ecosystem in which regression-based, probabilistic, distance-driven, shallow neural, and convolutional models operate under identical preprocessing, validation, and testing protocols. Beyond comparative performance analysis, interpretability is incorporated through Gradient-weighted Class Activation Mapping (Grad-CAM), enabling visualization of spatial attention patterns underlying convolutional predictions. A multi-metric evaluation strategy including accuracy, precision, recall, and F1-score provides comprehensive assessment of diagnostic reliability. Experimental results demonstrate a consistent performance hierarchy, with convolutional neural networks achieving superior discriminative capability and improved tumor sensitivity relative to classical approaches. By combining standardized benchmarking, interpretability integration, statistical validation, and deployment-aware evaluation, the proposed framework contributes a reproducible methodological reference for evidence-guided algorithm selection in medical imaging. The study advances transparent and clinically aligned artificial intelligence for MRI-based brain tumor detection.
Zitieren
APA
Jain, P., Jain, N., Panchikattil, S., Chikhale, D., Jadhav, J. S., & Sankpal, A. (2026). A Unified and Interpretable Benchmarking Framework for Brain Tumor Classification Using Classical and Deep Learning Models. International Journal of Drug Delivery Technology, 16(8s). https://doi.org/10.25258/ijddt.16.8s.1
Vancouver
Jain P, Jain N, Panchikattil S, Chikhale D, Jadhav JS, Sankpal A. A Unified and Interpretable Benchmarking Framework for Brain Tumor Classification Using Classical and Deep Learning Models. International Journal of Drug Delivery Technology. 2026;16(8s). doi:10.25258/ijddt.16.8s.1
BibTeX
@article{Jain2026,
author = {Jain, Preeti and Jain, Nitin and Panchikattil, Susheelkumar and Chikhale, Devidas and Jadhav, Jayendra S and Sankpal, Amol},
title = {A Unified and Interpretable Benchmarking Framework for Brain Tumor Classification Using Classical and Deep Learning Models},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {8s},
doi = {10.25258/ijddt.16.8s.1}
}
EUVIMED